These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 12500035)
21. [Health symptom-free women do not need preventive hormone replacement therapy. The risks outweigh the benefits; a large trial prematurely interrupted in the USA]. von Schoultz B Lakartidningen; 2002 Aug; 99(34):3276-8. PubMed ID: 12362844 [No Abstract] [Full Text] [Related]
22. A personal initiative for women's health: to challenge the Women's Health Initiative. Genazzani AR; Gambacciani M Gynecol Endocrinol; 2002 Aug; 16(4):255-7. PubMed ID: 12396552 [No Abstract] [Full Text] [Related]
23. From dearth to deluge. Marshall E Science; 2005 Jun; 308(5728):1570. PubMed ID: 15947167 [No Abstract] [Full Text] [Related]
26. Clinical appraisal of the Women's Health Initiative. Speroff L J Obstet Gynaecol Res; 2005 Apr; 31(2):80-93. PubMed ID: 15771632 [No Abstract] [Full Text] [Related]
27. Observational studies and clinical trials of menopausal hormone therapy: can they both be right? Allison MA; Manson JE Menopause; 2006; 13(1):1-3. PubMed ID: 16607089 [No Abstract] [Full Text] [Related]
28. After the Women's Health Initiative: decision making and trust of women taking hormone therapy. Schonberg MA; Davis RB; Wee CC Womens Health Issues; 2005; 15(4):187-95. PubMed ID: 16051110 [TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy: a time for pause. Yusuf S; Anand S CMAJ; 2002 Aug; 167(4):357-9. PubMed ID: 12197690 [No Abstract] [Full Text] [Related]
30. WHI trial: it's time to be critical! Speroff L Am J Obstet Gynecol; 2003 Sep; 189(3):620. PubMed ID: 14526277 [No Abstract] [Full Text] [Related]
31. The missing R. Gambacciani M; Genazzani AR Gynecol Endocrinol; 2003 Apr; 17(2):91-4. PubMed ID: 12741416 [No Abstract] [Full Text] [Related]
32. Women's health initiative. Eaker E; Hahn RA N Engl J Med; 1994 Jan; 330(1):70-1. PubMed ID: 8259163 [No Abstract] [Full Text] [Related]
33. Good science or good marketing? Head K Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780 [No Abstract] [Full Text] [Related]
34. Health risks after cessation of postmenopausal hormone therapy. Pines A; Sturdee D; Birkhäuser M; Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782 [No Abstract] [Full Text] [Related]
35. Long-term use of hormone therapy for urogenital complaints: is there a role? Hendrix SL Med Clin North Am; 2003 Sep; 87(5):1029-37. PubMed ID: 14621329 [TBL] [Abstract][Full Text] [Related]
36. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review. Abramson BL J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199 [TBL] [Abstract][Full Text] [Related]
37. Estrogens and women's health: a scary or a fairy tale? Genazzani AR; Gambacciani M; Simoncini T Gynecol Endocrinol; 2004 Apr; 18(4):175-8. PubMed ID: 15293887 [No Abstract] [Full Text] [Related]
38. Reassurance for many healthy women considering HRT. Shufelt C; Bairey Merz CN BMJ; 2017 Oct; 359():j4652. PubMed ID: 29030494 [No Abstract] [Full Text] [Related]
39. Women's health after WHI. Kenemans P Maturitas; 2005 May; 51(1):1-3. PubMed ID: 15883101 [No Abstract] [Full Text] [Related]
40. The complex interplay of vasomotor symptoms, hormone therapy, and cardiovascular risk. Allison MA; Manson JE Menopause; 2009; 16(4):619-20. PubMed ID: 19503007 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]